Apart from ibrutinib, patients with M-CLL, devoid of TP53 aberrations and match plenty of to tolerate FCR therapy, should still be very good candidates to the latter, Together with the reward becoming that this procedure can be done in 6 months although ibrutinib should be taken indefinitely. This feature would be specially worthwhile for non-compl… Read More